Skip to main content
Medical information Clinical review pending

Genetic Testing

MAGT1 Gene Immunodeficiency X-Linked with Magnesium Defect Epstein-Barr Virus Infection and Neoplasia Genetic Test

This genetic test identifies mutations in the MAGT1 gene, associated with X-linked immunodeficiency, magnesium defects, Epstein-Barr virus susceptibility, and neoplasia. Utilizes Next-Generation Sequencing (NGS) for accurate results.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for the blood draw. Discuss your medical history and family history with your doctor before the test. A clinical history assessment and genetic counseling session are recommended prior to testing.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the MAGT1 Gene Immunodeficiency X-Linked with Magnesium Defect Epstein-Barr Virus Infection and Neoplasia Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with a personal or family history of X-linked immunodeficiency.
  • ✓Patients experiencing recurrent or severe Epstein-Barr virus infections.
  • ✓Individuals with unexplained low magnesium levels (hypomagnesemia).
  • ✓Patients diagnosed with neoplasia potentially linked to immunodeficiency.
  • ✓Family members of individuals known to have a MAGT1 gene mutation.
  • ✓Individuals seeking genetic counseling for family planning due to a history of related conditions.
02

In plain language

What this test helps you understand

This test helps identify genetic mutations in the MAGT1 gene, which can confirm a diagnosis of MAGT1-related immunodeficiency, explain susceptibility to severe Epstein-Barr virus infections, and assess risk for associated neoplasia. Results can inform clinical management and genetic counseling.
The MAGT1 Gene Immunodeficiency X-Linked with Magnesium Defect test is a specialized genetic analysis designed to detect mutations within the MAGT1 gene. This gene plays a crucial role in magnesium transport and immune system function. Mutations in this gene are linked to a specific type of X-linked immunodeficiency, characterized by low magnesium levels, increased susceptibility to Epstein-Barr virus (EBV) infections, and an elevated risk of certain cancers (neoplasia).

This test employs advanced Next-Generation Sequencing (NGS) technology to provide a comprehensive and accurate assessment of the MAGT1 gene. It looks for specific changes in the DNA sequence that can cause the associated health conditions.

Understanding the genetic basis of these conditions can be vital for diagnosis, management, and family planning. Discussing the test with a healthcare provider or genetic counselor is recommended before proceeding.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for the blood draw. Discuss your medical history and family history with your doctor before the test. A clinical history assessment and genetic counseling session are recommended prior to testing.
SampleBlood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
MethodologyNext-Generation Sequencing (NGS) of the MAGT1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes the MAGT1 gene specifically. It does not detect mutations in other genes that may cause similar symptoms. Results must be interpreted by a qualified healthcare professional in conjunction with clinical findings. The test may not detect all possible mutations within the MAGT1 gene, although NGS technology aims for comprehensive coverage.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The MAGT1 gene provides instructions for making a protein involved in transporting magnesium ions across cell membranes. It is also important for the proper function of certain immune cells.
Mutations in the MAGT1 gene are associated with X-linked immunodeficiency characterized by low magnesium levels, increased susceptibility to Epstein-Barr virus infections, and an increased risk of developing certain cancers (neoplasia).
Individuals with a family history of related conditions, recurrent severe infections (especially EBV), unexplained low magnesium levels, or certain types of neoplasia may be candidates for this test. Consultation with a doctor is advised.
This test uses Next-Generation Sequencing (NGS), which is a highly accurate method for detecting genetic mutations. However, no genetic test is 100% perfect, and results should be interpreted by a healthcare professional.
It is crucial to discuss your results with your doctor or a genetic counselor. They can help you understand the implications of the findings and recommend appropriate next steps, including potential treatments or management strategies.
Insurance coverage varies. Please confirm coverage details with your insurance provider and the laboratory before booking the test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp